Gram-positive Bacterial Infections
Infectious Disease·MeSH: Bacterial Infections
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| oritavancin | TG THERAPEUTICS, INC. (TGTX) |
Frequently asked questions
How many drugs are in development for Gram-positive Bacterial Infections?
BioSniper tracks 1 drug in development for Gram-positive Bacterial Infections across 1 company.
How many clinical trials target Gram-positive Bacterial Infections?
There are 1 clinical trial targeting Gram-positive Bacterial Infections tracked by BioSniper.
Deep-dive into Gram-positive Bacterial Infections
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis